| GAFFX | USAUX | GAFFX / USAUX | |
| Total Expense Ratio | 0.29 | 0.64 | 45% |
| Annual Report Gross Expense Ratio | 0.29 | 0.64 | 45% |
| Fund Existence | 9 years | 44 years | - |
| Gain YTD | -0.994 | -2.853 | 35% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 336B | 2.76B | 12,156% |
| Annual Yield % from dividends | 0.55 | 0.00 | - |
| Returns for 1 year | 3.10 | 7.29 | 42% |
| Returns for 3 years | 46.51 | 83.27 | 56% |
| Returns for 5 years | 15.15 | 31.82 | 48% |
| Returns for 10 years | N/A | 111.27 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EITEX | 52.65 | 0.62 | +1.19% |
| Parametric Tax-Managed Emerg Mkt I | |||
| ETNHX | 51.17 | 0.44 | +0.87% |
| Eventide Healthcare & Life Sciences N | |||
| GOCAX | 16.49 | 0.12 | +0.73% |
| Gabelli International Small Cap A | |||
| ESMCX | 11.81 | 0.02 | +0.17% |
| Invesco Global Small Cap Equity C | |||
| CISIX | 56.55 | -0.55 | -0.96% |
| Calvert US Large Cap Core Rspnb Idx I | |||